MORGAN SHAFER: Open Payments
NPI 1487120457 · WICHITA FALLS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 10 payments from 7 companies in 2025. Trend: 2023 $895 · 2024 $901 · 2025 $438
Food & beverage: $396Education: $42
| Company | Payments | Amount |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | 1 | $121 |
| Lilly USA, LLC | 2 | $117 |
| E.R. Squibb & Sons, L.L.C. | 2 | $96 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| SOBI, INC | 1 | $26 |
| Alexion Pharmaceuticals, Inc. | 1 | $26 |
| Janssen Biotech, Inc. | 1 | $20 |
Products named: MYRISK, REBLOZYL, Doptelet, ULTOMIRIS, OPDIVO, ERLEADA, JEMPERLI, OJJAARA.
Industry payments across TX — which companies pay providers there.
